If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
As breast density becomes a more recognized risk factor for breast cancer, Royal Philips announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography (FFDM) system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.
Philips Healthcare introduced the IQon Spectral computed tomography (CT) system at RSNA 2013. It is the world’s first spectral-detector CT system built from the ground up for spectral imaging. It uses color to identify the composition of an image without involving time-consuming protocols.
Philips unveiled the Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
Royal Philips Electronics and Sectra announced an agreement to extend the term of their existing picture archiving and communication system (PACS) support partnership agreement.
Physicians have been utilizing conventional ultrasound, also known as b-mode ultrasound, for diagnostic imaging since the 1970s. However, over the past 10 years there have been significant technological improvements within the equipment, as well as development of new technologies that allowed ultrasound to become more widely adopted. Ultrasound equipment has gotten physically smaller, generates less heat and has become more power efficient. These upgrades, along with vast enhancements in image quality, have pushed ultrasound into the point-of-care setting. Point-of-care ultrasound has become widely performed in emergency rooms, PCP offices and obstetric practices. As healthcare reform continues to favor the use of more cost-effective solutions, this trend is expected to persist until ultrasound is used in every doctor’s office.
With concerns about radiation dose and reducing unnecessary imaging scans, advances in computed tomography (CT) systems have brought about technologies such as iterative reconstruction software, intraoperative capabilities and dose-tracking software. In addition, recent studies on the use of CT on select patient populations and the modality’s benefits in detecting certain cancers are showing that the risks of CT imaging can go both ways. While CT exams can add to a patient’s lifetime exposure to ionizing radiation, they can also be more beneficial in cases where magnetic resonance imaging (MRI) or ultrasound might not be able to detect early-stage cancers. Some of these trends in utilization indicate that appropriate low-dose CT imaging will be key across patient populations.
Wide bore magnetic resonance imaging (MRI) systems have allowed radiologists to offer patients the optimized comfort of conventional open bore systems, as well as the high-quality imaging of conventional closed bore systems. Because wide bore MRIs have broadened the demographic of patients who can be tested, the systems have gained widespread adoption in use, with many practices opting to equip their offices solely with wide bore systems.
Philips’ MobileDiagnost wDR system allows staff to bring radiography machines directly to patients, optimizing patient comfort. The detector technology and reduced need for retakes inherent to these machines contribute to the patients receiving a low X-ray dose, further enhancing patient experience.
There were three key trends in X-ray vascular imaging systems made evident from new products showcased at the Radiological Society of North America (RSNA) annual meeting in late 2012. These include new hardware and software to lower ionizing radiation doses and improve image quality, better dose tracking software, and enhanced maneuverability for improved patient access and use in the growing hybrid OR market. As interventional procedures become more complex, imaging times have increased, raising concerns that are now being addressed by vendors.
October 8, 2013 — Philips Healthcare kicked off Breast Cancer Awareness Month at its global healthcare headquarters in Andover, Mass. As part of its campaign, Philips is driving a mammogram truck on a three-month, 10,000-mile journey to visit hospitals and clinicians in more than 13 U.S. markets.